[Importance of factor II determination during treatments with vitamin K inhibitors].
D000925:Anticoagulants / Q000009:adverse effects; D001780:Blood Coagulation Tests; D005260:Female; D006406:Hematoma / Q000139:chemically induced; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008297:Male; D006472:Oral Hemorrhage / Q000139:chemically induced; D011516:Prothrombin / Q000032:analysis*; D011517:Prothrombin Time; D014812:Vitamin K / Q000037:antagonists & inhibitors*
D000925:Anticoagulants; D014812:Vitamin K; D011516:Prothrombin
Importance du dosage du facteur II au cours des traitements par les inhibiteurs de la vitamine K.